Noninvasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of diabetes, according to a study performed at Massachusetts General Hospital and Harvard Medical School in Boston, MA. This is the first study of its kind to apply noninvasive imaging techniques to diabetes research.

“With noninvasive MRI we have the ability to evaluate beta cell mass, a major factor of insulin secretion that is significantly reduced in type two diabetes and almost gone in type one,” said Anna Moore, MD, lead author of the study. “We are also able to detect inflammation of the pancreas and vascular changes associated with type one and type two diabetes. This opens a huge area that is closed right now,” said Dr. Moore.

“Knowing the number of functional beta cells left would allow physicians to develop the most appropriate treatment plans for their patients. It would also allow them to respond, change or manipulate those treatment plans at any time,” she said.

“Noninvasive MRI could no doubt tremendously assist in achieving insulin independence in patients with diabetes,” said Dr. Moore.

This study appears in the August issue of the American Journal of Roentgenology. For a copy of the full study, please contact Heather Curry via email at .(JavaScript must be enabled to view this email address) or at 703-390-9822.

About ARRS
The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Röentgen, who discovered the x-ray in 1895.

Contact:
Heather Curry 703-390-9822
571-291-5207 (cell)
Shawn Farley 703-648-8936
703-869-0292 (cell)